| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/13/2002 | US20020072540 For therapy, prophylaxis and diagnosis of respiratory distress syndrome or other pulmonary diseases that are associated with deficiency of lung surfactant |
| 06/13/2002 | US20020072503 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 06/13/2002 | US20020072499 Specifically an N-formyl-methionyl-leucyl ("f-Met-Leu") tri-or tetra-peptide; pathological fibrosis or those caused by trauma or surgery |
| 06/13/2002 | US20020072498 Method for administering ciliary neurotrophic factor to the brain |
| 06/13/2002 | US20020072497 Novel DNA and recombinant production of novel polypeptides |
| 06/13/2002 | US20020072496 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/13/2002 | US20020072495 LL-37 is an immunostimulant |
| 06/13/2002 | US20020072494 Angiogenesis inhibitor, K1-5 (protease-activated kringles 1-5) genetically engineered so it can be secreted from cells in which it is expressed; contains a secretory signal peptide and a pre-activation peptide derived from plasminogen |
| 06/13/2002 | US20020072493 To promote nerve regeneration or to confer neuroprotection by administering the T cells or a nervous system-specific antigen such as myelin basic protein |
| 06/13/2002 | US20020072489 Fibroblast growth factors (FGF); single unit dosage; treating coronary artery disease (atherosclerosis) |
| 06/13/2002 | US20020072488 Amino acid sequences of human transporter peptides and proteins that are related to the sugar transporter subfamily; identifying modulators of the transporter peptides |
| 06/13/2002 | US20020072487 Method for searching physiologically active substances, process for producing these substances and drugs found by the searching method |
| 06/13/2002 | US20020072115 Pancreatic islet cell growth factors |
| 06/13/2002 | US20020072107 Human osteoclast derived cathepsin |
| 06/13/2002 | US20020072101 Novel human nucleic acid molecules and polypeptides encoding cation channels |
| 06/13/2002 | US20020072092 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/13/2002 | US20020072091 Death domain containing receptor 5 |
| 06/13/2002 | US20020072090 Hr-1 receptor |
| 06/13/2002 | US20020072089 Novel ITALY, Lor-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor |
| 06/13/2002 | US20020072067 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/13/2002 | US20020072052 Compositions and methods for regulating bacterial pathogenesis |
| 06/13/2002 | US20020071873 Purified growth factor in a concentration of less than 1 x 10-6 molar. |
| 06/13/2002 | US20020071862 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions, and kit related thereto |
| 06/13/2002 | US20020071849 A41L protein or a chemokine-binding fragment thereof; detecting an interaction of the chemokine-binding molecule with a chemokine; antiinflammatory agents |
| 06/13/2002 | US20020071841 Recombinant toxin and monoclonal antibody which specifically binds to glial-derived or meningioma-derived tumor cells; screening for malignant gliomas and meningiomas; treating glioblastoma multiforme and astrocytomas. |
| 06/13/2002 | US20020071840 Method of therapeutic administration of anti-CD40L compounds |
| 06/13/2002 | US20020071838 Method for raising the blood glucose level in mammals |
| 06/13/2002 | US20020071837 Preferred hyaluronidase enzyme is devoid of molecular weight fractions below 40,000 MW, between 60-70,000 MW and above 100,OOO MW |
| 06/13/2002 | US20020071836 Preferred sugar-processing enzymes are cellulases and glucolytic enzymes. |
| 06/13/2002 | US20020071833 Hematopoietic stem cell gene therapy |
| 06/13/2002 | US20020071832 Use of mutant herpes viruses and anticancer agents in the treatment of cancer |
| 06/13/2002 | US20020071831 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/13/2002 | US20020071830 Expression vector is used to express a polypeptide comprising the core protein of a human polymorphic epithelial mucin, which core protein is specifically bound by monoclonal antibody, SM3. |
| 06/13/2002 | US20020071829 Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
| 06/13/2002 | US20020071828 Biocompatible cuff into which a system for expressing a neurotrophic factor is introduced. |
| 06/13/2002 | US20020071825 Methods and compositions for inducing an immune response |
| 06/13/2002 | US20020071824 Gene transfer to pancreatic b cells for prevention of islet dysfunction |
| 06/13/2002 | US20020071814 Administering a compound that either inhibits the synthesis of ceramide, blocks the activity of ceramide, or degrades ceramide. |
| 06/13/2002 | US20020071807 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 06/13/2002 | DE10059336A1 Herstellung von rekombinantem BMP-2 Production of recombinant BMP-2 |
| 06/13/2002 | DE10051983A1 Medicaments useful e.g. for preventing thrombosis, inhibiting transplant rejection or treating chronic inflammatory reactions comprises agents inhibiting binding of oxidized proteins to CD36, |
| 06/13/2002 | CA2716959A1 Glp-1 fusion proteins |
| 06/13/2002 | CA2436847A1 Treatment of cancer by reduction of intracellular energy and pyrimidines |
| 06/13/2002 | CA2436732A1 Protein modification and maintenance molecules |
| 06/13/2002 | CA2436666A1 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 06/13/2002 | CA2436519A1 Selection of catalytic nucleic acids targeted to infectious agents |
| 06/13/2002 | CA2436306A1 Basb221 polypeptides and polynucleotides encoding basb221 polypeptides |
| 06/13/2002 | CA2431374A1 Novel fibroblast growth factors |
| 06/13/2002 | CA2431203A1 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 06/13/2002 | CA2431193A1 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 06/13/2002 | CA2431179A1 Synthesis of small particles |
| 06/13/2002 | CA2430998A1 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma |
| 06/13/2002 | CA2430993A1 G-protein coupled receptors |
| 06/13/2002 | CA2430948A1 Caml-binding peptides |
| 06/13/2002 | CA2430716A1 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 06/13/2002 | CA2430624A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 06/13/2002 | CA2430621A1 Vaccine composition containing transforming growth factor alpha |
| 06/13/2002 | CA2430558A1 Proteins and nucleic acids encoding same |
| 06/13/2002 | CA2430379A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/13/2002 | CA2430191A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/13/2002 | CA2429959A1 Adipocyte complement related protein zacrp3x2 |
| 06/13/2002 | CA2429769A1 Methods of treatment involving human mda-7 |
| 06/13/2002 | CA2429641A1 Kinases and phosphatases |
| 06/13/2002 | CA2429094A1 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems |
| 06/13/2002 | CA2428390A1 Enzymes |
| 06/13/2002 | CA2428208A1 Lipid-associated molecules |
| 06/13/2002 | CA2428097A1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2002 | CA2428092A1 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 06/13/2002 | CA2425396A1 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 06/12/2002 | EP1213353A1 Peptide leukotriene receptor |
| 06/12/2002 | EP1213352A1 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 06/12/2002 | EP1213351A2 Nucleic acid enzymes acquiring an activity for cleaving a target RNA by recognising another molecule |
| 06/12/2002 | EP1213348A2 Parasite-derived resistance |
| 06/12/2002 | EP1213299A1 Immunogenic epitopes of human papilloma virus and uses thereof |
| 06/12/2002 | EP1213298A1 Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 06/12/2002 | EP1213297A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 06/12/2002 | EP1213032A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/12/2002 | EP1213029A1 Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection |
| 06/12/2002 | EP1213028A1 Hm1.24 antigen expression potentiators |
| 06/12/2002 | EP1213024A1 Cosmetic and/or dermopharmaceutical composition containing native proteins of Argania spinosa |
| 06/12/2002 | EP1212941A2 Modulating ramp activity |
| 06/12/2002 | EP1212464A2 Diagnostics and therapeutics for osteoporosis |
| 06/12/2002 | EP1212456A1 Antisense modulation of shp-2 expression |
| 06/12/2002 | EP1212455A1 Antisense modulation of telomeric repeat binding factor 1 expression |
| 06/12/2002 | EP1212436A2 Protein phosphatase and kinase proteins |
| 06/12/2002 | EP1212434A2 Human hydrolytic enzymes |
| 06/12/2002 | EP1212433A2 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 06/12/2002 | EP1212423A2 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a |
| 06/12/2002 | EP1212422A2 Human ctla-4 antibodies and their uses |
| 06/12/2002 | EP1212421A1 Gas1 polypeptides |
| 06/12/2002 | EP1212420A1 Conditional immortalisation of cells |
| 06/12/2002 | EP1212419A2 Polycyclic aromatic hydrocarbon induced molecules |
| 06/12/2002 | EP1212418A2 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
| 06/12/2002 | EP1212417A2 Interleukin-1-receptor associated kinase-3 (irak3) |
| 06/12/2002 | EP1212416A2 Nucleic acid based modulators of gene expression |
| 06/12/2002 | EP1212415A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212414A2 Polypeptides capable of interacting with the smad peptide and comprising the sequence pp(t/n)k |
| 06/12/2002 | EP1212410A2 Dna encoding the human serine protease eos |
| 06/12/2002 | EP1212407A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212404A2 Isolation of muscle-derived stem cells and uses therefore |